The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer

Over 300,000 patients develop squamous cell carcinoma of the head and neck (HNSCC) worldwide with 25-30% of patients ultimately dying from their disease. Currently, molecular biomarkers are not used in HNSCC but several genes have been identified including mutant TP53 (mutp53) Our recent work has id...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Coaxum, Sonya D., Tiedeken, Jessica, Garrett-Mayer, Elizabeth, Myers, Jeffrey, Rosenzweig, Steven A., Neskey, David M.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5410280/
https://ncbi.nlm.nih.gov/pubmed/28160562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14967
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados